“Tildrakizumab for Moderate-to-Severe Plaque Psoriasis: An Evidence-Based Review”. Canadian Dermatology Today 2, no. s03 (March 1, 2021): 3–8. Accessed March 19, 2026. https://canadiandermatologytoday.com/article/view/2-s03-devani-prajapati.